What is the ticker symbol for Immunic?

Immunic trades under the ticker IMUX on NASDAQ.

What sector does Immunic operate in?

Immunic is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IMUX in a portfolio?

PortView shows IMUX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Immunic (IMUX) Stock Analysis

NASDAQHealthcareBiotechnology

$14.33-1.75%

1-year price historyRange $5.10 – $16.90

52-week range$14.33

$5.06$17.43

What Immunic does

Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditions. Its primary investigational compound, IMU-838, has advanced to Phase 2 clinical trials, targeting relapsing-remitting multiple sclerosis (RRMS), inflammatory bowel disease (IBD), various other chronic inflammatory and autoimmune disorders, and also coronavirus disease. Additionally, the company is advancing IMU-935, which functions as an inverse agonist of RORγt, and IMU-856, designed to restore the intestinal barrier for patients afflicted with conditions like inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor-induced colitis, and other ailments affecting intestinal barrier integrity. The company's headquarters are located in New York, New York.

Key metrics

Market cap

$195.13M

P/E (TTM)

-5.49

EPS (TTM)

$-2.61

Beta

1.40

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$15.07

200-day avg

$10.93

52-week high

$17.43

52-week low

$5.06

CEO

Erik Lundgren

ETFs linked to IMUX

Broad-market and Healthcare sector ETFs an investor holding Immunic is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IMUX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IMUX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Immunic?: Immunic trades under the ticker IMUX on NASDAQ.
Which exchange is IMUX listed on?: IMUX is listed on NASDAQ.
What sector does Immunic operate in?: Immunic is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IMUX in a portfolio?: PortView shows IMUX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.